Results 31 to 40 of about 15,263 (254)

Investigating the role of allergic contact dermatitis in residual ocular surface disease on dupilumab (ROSDD)

International Journal of Women's Dermatology, 2019
Background: The mechanisms underlying eye-related complications with dupilumab are poorly understood. Objective: This study aimed to determine the incidence and characteristics of ocular complications with dupilumab and the prevalence of comorbid ...
Jodie Raffi, BA, Raagini Suresh, BS, Harvey Fishman, MD, PhD, Nina Botto, MD, Jenny E. Murase, MD   +4 more
doaj   +1 more source

Dupilumab-associated ocular surface disease: a case report

, 2022
Aims: Australian dermatologists are becoming familiar with prescribing dupilumab since it was listed on the PBS on the 1st March 2021. The presentation, management and long-term sequelae of dupilumab-associated ocular surface disease is discussed as ...
Sander, Christina, O'Bryen, John
core   +1 more source

Two‐sided influence of dupilumab on alopecia areata co‐existing with severe atopic dermatitis: A case series and literature review

Journal of Cutaneous Immunology and Allergy, 2023
Objectives Alopecia areata (AA) often coexists with atopic dermatitis (AD). Recently, several reports suggested that dupilumab, an interleukin 4 receptor α‐antagonist, administration could be a promising medication not only for severe AD but also for AA ...
Masahiro Fukuyama, Misaki Kinoshita‐Ise, Yoshiko Mizukawa, Manabu Ohyama   +3 more
doaj   +1 more source

Conjunctivitis in dupilumab clinical trials [PDF]

, 2019
BACKGROUND: Dupilumab, which blocks the shared receptor component for interleukin (IL)-4 and IL-13, is approved for inadequately-controlled moderate-to-severe atopic dermatitis (AD) and moderate-to-severe eosinophilic or oral corticosteroid-dependent ...
Akpek, E., Akpek, E, Chen, Z., Mannent, L., de Bruin-Weller, M., Hirano, I, Simpson, EL, Wollenberg, A., Wollenberg, A. (A.), Graham, N.M.H., Cork, MJ, Pirozzi, G, Prens, E., Weyne, J., Asbell, P., Corren, J, Zhu, X, Corren, J., Hamilton, J.D., Hultsch, T., Bachert, Claus, Davis, JD, Simpson, E.L., Ardeleanu, M., Bruin-Weller, M, Bachert, C., Shumel, B., Prens, E.P. (Errol), Shumel, B, Cork, M.J., Asbell, P, Guttman-Yassky, E, Bachert, C, Guttman-Yassky, E., Chen, Z, Davis, J.D., Bruin-Weller, M. (Marjolein), Weyne, J, Staudinger, H, Staudinger, H., Mannent, L, Blauvelt, A., Teper, A., Graham, NMH, Guttman-Yassky, E. (Emma), Hamilton, JD, Bruin‐Weller, M., Zhu, X.D. (Xiaoye), Hultsch, T, Zhu, X., Korotzer, A, Akinlade, B, Hirano, I., Bachert, C. (Claus), Wollenberg, A, Rizova, E, Guttman‐Yassky, E., Blauvelt, A, Prens, Errol, Rizova, E., Pirozzi, G., Akinlade, B., Chen, Z. (Zhongli), Teper, A, Ardeleanu, M, Korotzer, A.   +65 more
core   +4 more sources

Management of dupilumab-associated ocular surface diseases in atopic dermatitis patients [PDF]

, 2021
Atopic dermatitis is a chronic inflammatory skin disease characterised by eczematous skin lesions and intense pruritus. It is often associated with other atopic diseases such as allergic rhinitis and conjunctivitis, bronchial asthma and eosinophilic ...
Thormann, Kathrin, Simon, Dagmar; https://orcid.org/, Guex-Crosier, Y., Kaspar Schürch, Di-Lucca, Julie, Emmanuel Laffitte, Schmid-Grendelmeier, Peter, Guex-Crosier, Yan, Peter Schmid-Grendelmeier, Schürch, K., Dagmar Simon, Laffitte, Emmanuel, Häusermann, Peter, Schürch, Kaspar, Yan Guex-Crosier, Laffitte, E., Julie Di-Lucca, Peter Häusermann, Ieva Saulite, Saulite, Ieva, Häusermann, P., Simon, D., Di-Lucca, J., Saulite, I., Kathrin Thormann, Laffitte, Emmanuel Alexis, Schmid-Grendelmeier, P., Thormann, K., Simon, Dagmar   +28 more
core   +2 more sources

Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study

, 2021
Background: Treatment of moderate-to-severe atopic dermatitis (AD) in the elderly may be challenging, due to side-effects of traditional anti-inflammatory drugs and to comorbidities often found in this age group.
Foti C, Stinco G, Ferrucci SM, Rossi M, Stingeni L, Amerio P, Offidani A, Potenza C, Peris K, Nettis E, Pigatto P D, Girolomoni G, Argenziano G, Napolitano M, Esposito M, Patruno C, Belloni Fortina A, Ortoncelli M, Grieco T, DADE - Dupilumab for Atopic Dermatitis of the Elderly study group, Guarneri F, Amoruso G F, Talamonti M, Loi C, Iannone MT, Rongioletti F, Fabbrocini G, Malara G, Cristaudo A, Corazza M, Gattoni M   +30 more
core   +1 more source

Reduction in hospitalisations with dupilumab in Japanese adults with atopic dermatitis in a real‐world setting

JEADV Clinical Practice, 2023
Background In a recent post hoc analysis of multinational clinical trial data, dupilumab treatment for patients with moderate or severe atopic dermatitis (AD) reduced all‐cause and AD‐related hospitalisations.
Ken Igawa, Hiroyuki Fujita, Yuki Tajima, Robert Lubwama, Moataz Daoud, Zhixiao Wang, Kazuhiko Arima   +6 more
doaj   +1 more source

Eosinophilic granulomatosis with polyangiitis developed after dupilumab administration in patients with eosinophilic chronic rhinosinusitis and asthma: a case report

BMC Pulmonary Medicine, 2023
Background Eosinophilic granulomatosis with polyangiitis (EGPA) is a form of anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis characterized by eosinophil-rich granulomatous inflammation and small-to-medium vessel vasculitis associated ...
Isao Suzaki, Akihiko Tanaka, Ryo Yanai, Yuki Maruyama, Sawa Kamimura, Kojiro Hirano, Hitome Kobayashi   +6 more
doaj   +1 more source

Real-world treatment patterns in patients with chronic rhinosinusitis with nasal polyps who initiated dupilumab: A US claims analysis

Journal of Allergy and Clinical Immunology: Global
Background: Dupilumab was approved as an add-on maintenance treatment for adult patients with inadequately controlled chronic rhinosinusitis with nasal polyps based on the pivotal phase 3 trials.
Jayant M. Pinto, MD, Mirko Fillbrunn, PhD, Bruno Martins, PhD, Min Yang, PhD, Chao Chen, PhD, Scott Nash, MD, Mark Corbett, MD, Aakash Gandhi, PhD, Zhixiao Wang, PhD   +8 more
doaj   +1 more source

Hypereosinophilic Dermatitis: Successful Treatment with Dupilumab

, 2023
Chenyu Wu, Jianzhong Zhang, Yan Zhao Department of Dermatology, People’s Hospital of Peking University, Beijing, People’s Republic of ChinaCorrespondence: Yan Zhao, Email 13311373780@163.comAbstract: Hypereosinophilic dermatitis (HED) is a subtype of ...
Zhang J, Wu C, Zhao Y
core